Symbioken is a French start-up company created in 2011. Symbioken has developed a device, named AmeaCell®, to be used by esthetic surgeons for their patients for wrinkles filling. AmeaCell® allows the extraction of both stem cells and matrix from the patient, for re-injection into the same patient’s face wrinkles for filling them and skin repair. The device is currently under clinical investigation.